Viewing
|Articles|March 1, 2002

Study results point to efficacy of once-daily bimatoprost

Indianapolis-Pooled 6-month data from two multicenter, double-blind, parallel studies demonstrate that once-daily treatment with bimatoprost ophthalmic solution 0.03% (Lumigan, Allergan) is safe and more effective than timolol 0.5% for controlling elevated IOP, said Louis B. Cantor, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME